Back

Hydrodynamic shear enables enrichment of functional tumor antigen-reactive T cells

Subramanian, P. S.; Fu, M.; Semaan, L. C.; Sher, A. S.; Shergill, B. S.; George, S. C.; Shirure, V. S.

2026-07-08 bioengineering
10.64898/2026.07.08.737133 bioRxiv
Show abstract

Adoptive T-cell therapies rely on the identification and expansion of rare tumor-reactive T cells, yet current enrichment strategies are limited by the low abundance of these cells and complexity of their functional enrichment. Here, we present a microfluidic platform that exploits hydrodynamic shear as a controllable parameter for enriching antigen-specific T cells through peptide-major histocompatibility complex (pMHC)-mediated capture. An eight-channel microfluidic device was engineered to simultaneously interrogate a range of wall shear stresses while maintaining uniform cell delivery, enabling systematic identification of shear conditions that maximize antigen-specific enrichment. Using engineered MART-1-specific Jurkat cells, we demonstrate that T-cell capture is jointly regulated by wall shear stress and pMHC density, with intermediate shear preferentially enriching antigen-specific cells over nonspecific binders. Translation of the optimal operating condition to a high-throughput single-shear device enabled approximately 35-fold enrichment of antigen-specific T cells from peripheral blood mononuclear cells containing only 0.05% target cells. We further show that peptide-MHC complexes isolated directly from melanoma whole-cell lysates support shear-dependent enrichment comparable to recombinant pMHCs. Finally, primary MART-1-specific CD8 T cells enriched using tumor-derived pMHCs retained the ability to recognize melanoma cells and upregulated the activation marker CD137 following antigen-specific stimulation. Together, these findings establish hydrodynamic shear as an orthogonal parameter for antigen-specific T-cell enrichment and provide a framework for integrating force-based selection with tumor-derived pMHCs to isolate functional antigen-specific T cells using tumor-derived pMHCs.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Lab on a Chip
96 papers in training set
Top 0.1%
18.4%
2
Advanced Science
286 papers in training set
Top 0.2%
11.9%
3
Nature Communications
5641 papers in training set
Top 21%
7.8%
4
Science Advances
1243 papers in training set
Top 3%
6.7%
5
Advanced Healthcare Materials
85 papers in training set
Top 0.4%
5.5%
50% of probability mass above
6
ACS Nano
113 papers in training set
Top 0.4%
5.5%
7
Small
78 papers in training set
Top 0.2%
4.8%
8
Small Methods
29 papers in training set
Top 0.1%
3.2%
9
APL Bioengineering
19 papers in training set
Top 0.1%
3.2%
10
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 22%
2.4%
11
Scientific Reports
3612 papers in training set
Top 51%
1.9%
12
Advanced Functional Materials
46 papers in training set
Top 0.7%
1.9%
13
Bioengineering & Translational Medicine
21 papers in training set
Top 0.3%
1.7%
14
Nano Letters
71 papers in training set
Top 0.7%
1.7%
15
Nature Biomedical Engineering
47 papers in training set
Top 0.7%
1.7%
16
Analytical Chemistry
218 papers in training set
Top 2%
1.5%
17
Communications Biology
993 papers in training set
Top 22%
1.1%
18
eLife
5828 papers in training set
Top 58%
1.1%
19
Cell Reports Methods
165 papers in training set
Top 4%
0.8%
20
Nature Nanotechnology
32 papers in training set
Top 0.7%
0.6%
21
PLOS ONE
5266 papers in training set
Top 65%
0.6%
22
Journal of Biological Engineering
12 papers in training set
Top 0.2%
0.6%